Solazyme Lists on Nasdaq

Algae oils firm Solazyme (San Francisco) says its common stock began trading on the Nasdaq Global Select Market today after the successful launch of an initial public offering (IPO). The IPO, priced at $18/share, raised about $197.5 million, more than the company’s earlier expectations of about $184 million. In addition, Solazyme says it has granted the underwriters a 30-day option to purchase up to an additional 1,646,250 shares of common stock, solely to cover over-allotments, if any. Morgan Stanley and Goldman Sachs are lead underwriters for the deal...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers